 | • レポートコード：D005-04481 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、避妊薬＆器具の世界市場を広く調査・分析し、今後の市場展望をまとめております。避妊薬＆器具の種類別市場規模（避妊薬（経口避妊薬、注射用避妊薬、局所避妊薬）、避妊具（男性用避妊具、女性用避妊具））、用途別市場規模（女性用、男性用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Teva Pharmaceutical Industries Ltd、Cooper Surgical, Inc、Pfizer, Inc、Church & Dwight Co. Inc、The Female Health Company、Reckitt Benckiser Plc、Cipla Limited、Mayer Laboratories, Inc、Bayer AG、Allergan plc、Merck & Co. Inc ・地域別グローバル市場分析 2015年-2020年 ・避妊薬＆器具の北米市場（アメリカ、カナダ、メキシコ） ・避妊薬＆器具のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・避妊薬＆器具のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・避妊薬＆器具の南米市場（ブラジル、アルゼンチン） ・避妊薬＆器具の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：避妊薬（経口避妊薬、注射用避妊薬、局所避妊薬）、避妊具（男性用避妊具、女性用避妊具） ・用途別分析：女性用、男性用 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Contraceptives Drugs and Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.5% in the forecast period of 2020 to 2025 and will expected to reach USD 24150 million by 2025, from USD 18110 million in 2019.
The Contraceptives Drugs and Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Contraceptives Drugs and Devices market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Contraceptives Drugs and Devices market has been segmented into
Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
By Application, Contraceptives Drugs and Devices has been segmented into:
Female
Male
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Contraceptives Drugs and Devices market presented in the report. This section sheds light on the sales growth of different regional and country-level Contraceptives Drugs and Devices markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Contraceptives Drugs and Devices market.
The report offers in-depth assessment of the growth and other aspects of the Contraceptives Drugs and Devices market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Contraceptives Drugs and Devices Market Share Analysis
Contraceptives Drugs and Devices competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Contraceptives Drugs and Devices sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Contraceptives Drugs and Devices sales, revenue and market share for each player covered in this report.
The major players covered in Contraceptives Drugs and Devices are:
Teva Pharmaceutical Industries Ltd
Cooper Surgical, Inc
Pfizer, Inc
Church & Dwight Co. Inc
The Female Health Company
Reckitt Benckiser Plc
Cipla Limited
Mayer Laboratories, Inc
Bayer AG
Allergan plc
Merck & Co. Inc
Among other players domestic and global, Contraceptives Drugs and Devices market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Contraceptives Drugs and Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Contraceptives Drugs and Devices, with price, sales, revenue and global market share of Contraceptives Drugs and Devices in 2018 and 2019.
Chapter 3, the Contraceptives Drugs and Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Contraceptives Drugs and Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Contraceptives Drugs and Devices market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Contraceptives Drugs and Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Contraceptives Drugs and Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Contraceptives Drugs and Devices Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
1.2.3 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
1.3 Market Analysis by Application
1.3.1 Overview: Global Contraceptives Drugs and Devices Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Female
1.3.3 Male
1.4 Overview of Global Contraceptives Drugs and Devices Market
1.4.1 Global Contraceptives Drugs and Devices Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva Pharmaceutical Industries Ltd
2.1.1 Teva Pharmaceutical Industries Ltd Details
2.1.2 Teva Pharmaceutical Industries Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva Pharmaceutical Industries Ltd SWOT Analysis
2.1.4 Teva Pharmaceutical Industries Ltd Product and Services
2.1.5 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cooper Surgical, Inc
2.2.1 Cooper Surgical, Inc Details
2.2.2 Cooper Surgical, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cooper Surgical, Inc SWOT Analysis
2.2.4 Cooper Surgical, Inc Product and Services
2.2.5 Cooper Surgical, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer, Inc
2.3.1 Pfizer, Inc Details
2.3.2 Pfizer, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer, Inc SWOT Analysis
2.3.4 Pfizer, Inc Product and Services
2.3.5 Pfizer, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Church & Dwight Co. Inc
2.4.1 Church & Dwight Co. Inc Details
2.4.2 Church & Dwight Co. Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Church & Dwight Co. Inc SWOT Analysis
2.4.4 Church & Dwight Co. Inc Product and Services
2.4.5 Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 The Female Health Company
2.5.1 The Female Health Company Details
2.5.2 The Female Health Company Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 The Female Health Company SWOT Analysis
2.5.4 The Female Health Company Product and Services
2.5.5 The Female Health Company Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Reckitt Benckiser Plc
2.6.1 Reckitt Benckiser Plc Details
2.6.2 Reckitt Benckiser Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Reckitt Benckiser Plc SWOT Analysis
2.6.4 Reckitt Benckiser Plc Product and Services
2.6.5 Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cipla Limited
2.7.1 Cipla Limited Details
2.7.2 Cipla Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cipla Limited SWOT Analysis
2.7.4 Cipla Limited Product and Services
2.7.5 Cipla Limited Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Mayer Laboratories, Inc
2.8.1 Mayer Laboratories, Inc Details
2.8.2 Mayer Laboratories, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Mayer Laboratories, Inc SWOT Analysis
2.8.4 Mayer Laboratories, Inc Product and Services
2.8.5 Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer AG
2.9.1 Bayer AG Details
2.9.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer AG SWOT Analysis
2.9.4 Bayer AG Product and Services
2.9.5 Bayer AG Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Allergan plc
2.10.1 Allergan plc Details
2.10.2 Allergan plc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Allergan plc SWOT Analysis
2.10.4 Allergan plc Product and Services
2.10.5 Allergan plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Merck & Co. Inc
2.11.1 Merck & Co. Inc Details
2.11.2 Merck & Co. Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Merck & Co. Inc SWOT Analysis
2.11.4 Merck & Co. Inc Product and Services
2.11.5 Merck & Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Contraceptives Drugs and Devices Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Contraceptives Drugs and Devices Manufacturer Market Share in 2019
3.3.2 Top 6 Contraceptives Drugs and Devices Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Contraceptives Drugs and Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Contraceptives Drugs and Devices Sales and Market Share by Regions (2015-2020)
4.1.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Regions (2015-2020)
4.2 North America Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
4.3 Europe Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
4.5 South America Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Country
5.1.1 North America Contraceptives Drugs and Devices Sales and Market Share by Country (2015-2020)
5.1.2 North America Contraceptives Drugs and Devices Revenue and Market Share by Country (2015-2020)
5.2 United States Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
5.3 Canada Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
5.4 Mexico Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Contraceptives Drugs and Devices Sales, Revenue and Market Share by Country
6.1.1 Europe Contraceptives Drugs and Devices Sales and Market Share by Country (2015-2020)
6.1.2 Europe Contraceptives Drugs and Devices Revenue and Market Share by Country (2015-2020)
6.2 Germany Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
6.3 UK Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
6.4 France Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
6.5 Russia Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
6.6 Italy Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Contraceptives Drugs and Devices Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Contraceptives Drugs and Devices Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Contraceptives Drugs and Devices Revenue and Market Share by Regions (2015-2020)
7.2 China Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
7.3 Japan Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
7.4 Korea Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
7.5 India Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
7.7 Australia Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Country
8.1.1 South America Contraceptives Drugs and Devices Sales and Market Share by Country (2015-2020)
8.1.2 South America Contraceptives Drugs and Devices Revenue and Market Share by Country (2015-2020)
8.2 Brazil Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
8.3 Argentina Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Contraceptives Drugs and Devices Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Contraceptives Drugs and Devices Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Contraceptives Drugs and Devices Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
9.3 Turkey Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
9.4 Egypt Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
9.5 South Africa Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Contraceptives Drugs and Devices Sales and Market Share by Type (2015-2020)
10.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Type (2015-2020)
10.3 Global Contraceptives Drugs and Devices Price by Type (2015-2020)
11 Global Contraceptives Drugs and Devices Market Segment by Application
11.1 Global Contraceptives Drugs and Devices Sales Market Share by Application (2015-2020)
11.2 Global Contraceptives Drugs and Devices Revenue Market Share by Application (2015-2020)
11.3 Global Contraceptives Drugs and Devices Price by Application (2015-2020)
12 Market Forecast
12.1 Global Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2021-2025)
12.2 Contraceptives Drugs and Devices Market Forecast by Regions (2021-2025)
12.2.1 North America Contraceptives Drugs and Devices Market Forecast (2021-2025)
12.2.2 Europe Contraceptives Drugs and Devices Market Forecast (2021-2025)
12.2.3 Asia-Pacific Contraceptives Drugs and Devices Market Forecast (2021-2025)
12.2.4 South America Contraceptives Drugs and Devices Market Forecast (2021-2025)
12.2.5 Middle East & Africa Contraceptives Drugs and Devices Market Forecast (2021-2025)
12.3 Contraceptives Drugs and Devices Market Forecast by Type (2021-2025)
12.3.1 Global Contraceptives Drugs and Devices Sales Forecast by Type (2021-2025)
12.3.2 Global Contraceptives Drugs and Devices Market Share Forecast by Type (2021-2025)
12.4 Contraceptives Drugs and Devices Market Forecast by Application (2021-2025)
12.4.1 Global Contraceptives Drugs and Devices Sales Forecast by Application (2021-2025)
12.4.2 Global Contraceptives Drugs and Devices Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Contraceptives Drugs and Devices Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Contraceptives Drugs and Devices by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Contraceptives Drugs and Devices Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Major Business
Table 9. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)
Table 10. Teva Pharmaceutical Industries Ltd SWOT Analysis
Table 11. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product and Services
Table 12. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Cooper Surgical, Inc Basic Information, Manufacturing Base and Competitors
Table 14. Cooper Surgical, Inc Contraceptives Drugs and Devices Major Business
Table 15. Cooper Surgical, Inc Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)
Table 16. Cooper Surgical, Inc SWOT Analysis
Table 17. Cooper Surgical, Inc Contraceptives Drugs and Devices Product and Services
Table 18. Cooper Surgical, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer, Inc Contraceptives Drugs and Devices Major Business
Table 21. Pfizer, Inc Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)
Table 22. Pfizer, Inc SWOT Analysis
Table 23. Pfizer, Inc Contraceptives Drugs and Devices Product and Services
Table 24. Pfizer, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Church & Dwight Co. Inc Basic Information, Manufacturing Base and Competitors
Table 26. Church & Dwight Co. Inc Contraceptives Drugs and Devices Major Business
Table 27. Church & Dwight Co. Inc Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)
Table 28. Church & Dwight Co. Inc SWOT Analysis
Table 29. Church & Dwight Co. Inc Contraceptives Drugs and Devices Product and Services
Table 30. Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. The Female Health Company Basic Information, Manufacturing Base and Competitors
Table 32. The Female Health Company Contraceptives Drugs and Devices Major Business
Table 33. The Female Health Company Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)
Table 34. The Female Health Company SWOT Analysis
Table 35. The Female Health Company Contraceptives Drugs and Devices Product and Services
Table 36. The Female Health Company Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Reckitt Benckiser Plc Basic Information, Manufacturing Base and Competitors
Table 38. Reckitt Benckiser Plc Contraceptives Drugs and Devices Major Business
Table 39. Reckitt Benckiser Plc Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)
Table 40. Reckitt Benckiser Plc SWOT Analysis
Table 41. Reckitt Benckiser Plc Contraceptives Drugs and Devices Product and Services
Table 42. Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Cipla Limited Basic Information, Manufacturing Base and Competitors
Table 44. Cipla Limited Contraceptives Drugs and Devices Major Business
Table 45. Cipla Limited Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)
Table 46. Cipla Limited SWOT Analysis
Table 47. Cipla Limited Contraceptives Drugs and Devices Product and Services
Table 48. Cipla Limited Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Mayer Laboratories, Inc Basic Information, Manufacturing Base and Competitors
Table 50. Mayer Laboratories, Inc Contraceptives Drugs and Devices Major Business
Table 51. Mayer Laboratories, Inc Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)
Table 52. Mayer Laboratories, Inc SWOT Analysis
Table 53. Mayer Laboratories, Inc Contraceptives Drugs and Devices Product and Services
Table 54. Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 56. Bayer AG Contraceptives Drugs and Devices Major Business
Table 57. Bayer AG Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)
Table 58. Bayer AG SWOT Analysis
Table 59. Bayer AG Contraceptives Drugs and Devices Product and Services
Table 60. Bayer AG Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Allergan plc Basic Information, Manufacturing Base and Competitors
Table 62. Allergan plc Contraceptives Drugs and Devices Major Business
Table 63. Allergan plc Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)
Table 64. Allergan plc SWOT Analysis
Table 65. Allergan plc Contraceptives Drugs and Devices Product and Services
Table 66. Allergan plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Merck & Co. Inc Basic Information, Manufacturing Base and Competitors
Table 68. Merck & Co. Inc Contraceptives Drugs and Devices Major Business
Table 69. Merck & Co. Inc Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)
Table 70. Merck & Co. Inc SWOT Analysis
Table 71. Merck & Co. Inc Contraceptives Drugs and Devices Product and Services
Table 72. Merck & Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Contraceptives Drugs and Devices Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global Contraceptives Drugs and Devices Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Contraceptives Drugs and Devices Sales by Regions (2015-2020) (K Units)
Table 76. Global Contraceptives Drugs and Devices Sales Market Share by Regions (2015-2020)
Table 77. Global Contraceptives Drugs and Devices Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Contraceptives Drugs and Devices Sales by Countries (2015-2020) (K Units)
Table 79. North America Contraceptives Drugs and Devices Sales Market Share by Countries (2015-2020)
Table 80. North America Contraceptives Drugs and Devices Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Contraceptives Drugs and Devices Revenue Market Share by Countries (2015-2020)
Table 82. Europe Contraceptives Drugs and Devices Sales by Countries (2015-2020) (K Units)
Table 83. Europe Contraceptives Drugs and Devices Sales Market Share by Countries (2015-2020)
Table 84. Europe Contraceptives Drugs and Devices Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Contraceptives Drugs and Devices Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific Contraceptives Drugs and Devices Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Contraceptives Drugs and Devices Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Contraceptives Drugs and Devices Sales by Countries (2015-2020) (K Units)
Table 89. South America Contraceptives Drugs and Devices Sales Market Share by Countries (2015-2020)
Table 90. South America Contraceptives Drugs and Devices Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Contraceptives Drugs and Devices Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Contraceptives Drugs and Devices Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Contraceptives Drugs and Devices Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Contraceptives Drugs and Devices Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Contraceptives Drugs and Devices Revenue Market Share by Countries (2015-2020)
Table 96. Global Contraceptives Drugs and Devices Sales by Type (2015-2020) (K Units)
Table 97. Global Contraceptives Drugs and Devices Sales Share by Type (2015-2020)
Table 98. Global Contraceptives Drugs and Devices Revenue by Type (2015-2020) (USD Million)
Table 99. Global Contraceptives Drugs and Devices Revenue Share by Type (2015-2020)
Table 100. Global Contraceptives Drugs and Devices Sales by Application (2015-2020) (K Units)
Table 101. Global Contraceptives Drugs and Devices Sales Share by Application (2015-2020)
Table 102. Global Contraceptives Drugs and Devices Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global Contraceptives Drugs and Devices Market Share Forecast by Regions (2021-2025)
Table 104. Global Contraceptives Drugs and Devices Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global Contraceptives Drugs and Devices Market Share Forecast by Type (2021-2025)
Table 106. Global Contraceptives Drugs and Devices Sales Forecast by Application (2021-2025)
Table 107. Global Contraceptives Drugs and Devices Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Contraceptives Drugs and Devices Picture
Figure 2. Global Sales Market Share of Contraceptives Drugs and Devices by Type in 2019
Figure 3. Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Picture
Figure 4. Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Picture
Figure 5. Contraceptives Drugs and Devices Sales Market Share by Application in 2018
Figure 6. Female Picture
Figure 7. Male Picture
Figure 8. Global Contraceptives Drugs and Devices Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Contraceptives Drugs and Devices Sales Market Share by Manufacturer in 2019
Figure 29. Global Contraceptives Drugs and Devices Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Contraceptives Drugs and Devices Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Contraceptives Drugs and Devices Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Contraceptives Drugs and Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Contraceptives Drugs and Devices Revenue Market Share by Regions (2015-2020)
Figure 36. Global Contraceptives Drugs and Devices Revenue Market Share by Regions in 2018
Figure 37. North America Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
Figure 38. Europe Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
Figure 40. South America Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)
Figure 42. North America Contraceptives Drugs and Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Contraceptives Drugs and Devices Sales Market Share by Countries (2015-2020)
Figure 44. North America Contraceptives Drugs and Devices Sales Market Share by Countries in 2018
Figure 45. North America Contraceptives Drugs and Devices Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Contraceptives Drugs and Devices Revenue Market Share by Countries in 2018
Figure 47. United States Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Contraceptives Drugs and Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Contraceptives Drugs and Devices Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Contraceptives Drugs and Devices Revenue Market Share by Countries in 2019
Figure 53. Germany Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Contraceptives Drugs and Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Contraceptives Drugs and Devices Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Contraceptives Drugs and Devices Revenue Market Share by Regions 2019
Figure 61. China Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Contraceptives Drugs and Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Contraceptives Drugs and Devices Sales Market Share by Countries in 2019
Figure 68. South America Contraceptives Drugs and Devices Revenue Market Share by Countries in 2019
Figure 69. Brazil Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Contraceptives Drugs and Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Contraceptives Drugs and Devices Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Contraceptives Drugs and Devices Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Contraceptives Drugs and Devices Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Contraceptives Drugs and Devices Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Contraceptives Drugs and Devices Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Contraceptives Drugs and Devices Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Contraceptives Drugs and Devices Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Contraceptives Drugs and Devices Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Contraceptives Drugs and Devices Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Contraceptives Drugs and Devices Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
女性用避妊薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Female Contraceptives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Female Contraceptives m…- 緊急避妊薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Emergency Contraceptives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Emergency Contracept…
- 配合経口避妊薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Combined Hormonal Contraceptives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 20710 million by 2025, from USD 18300 million in 2019. The Combi…
- 女性用滅菌装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Female Sterilization Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Female Steriliza…
- 口腔粘膜炎治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Drugs for Oral Mucositis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drugs for Oral Mucos…